Showing 9,361 - 9,380 results of 18,262 for search 'significantly ((((linear decrease) OR (((we decrease) OR (a decrease))))) OR (larger decrease))', query time: 0.59s Refine Results
  1. 9361

    <b>Metabolic Perturbations and Ectopic Fat Deposition in Low Birthweight Subjects</b><b>– Effects of a 4 Week Carbohydrate Overfeeding Challenge</b> by Charlotte Brøns (261017)

    Published 2025
    “…Subcutaneous adipose tissue (SAT) density was lower in LBW subjects and decreased during COF in both groups. Serum alanine, phosphatidylcholines, and triglycerides increased significantly more in LBW subjects during COF. …”
  2. 9362

    Integrating legumes into cropping systems enhances soil carbon and nitrogen content while reduces the soil carbon-to-nitrogen ratio: A global meta-analysis by Zhiqiang Lu (20145192)

    Published 2025
    “…Moreover, SOC and STN increased when legumes replaced fallow or gramineous soil, whereas SCN significantly decreased only when legumes replaced gramineous systems. …”
  3. 9363
  4. 9364

    Image 1_A WRKY transcription factor, SlWRKY75, positively regulates tomato (Solanum lycopersicum L.) resistance to Ralstonia solanacearum.tif by Na Chen (153323)

    Published 2025
    “…In this study, subcellular localization revealed that SlWRKY75 is located in the nucleus, while the transcriptional activation assay indicated that SlWRKY75 acts as a transcriptional activator. To investigate the functional role of SlWRKY75, we generated overexpression transgenic lines. …”
  5. 9365

    Table 2_A WRKY transcription factor, SlWRKY75, positively regulates tomato (Solanum lycopersicum L.) resistance to Ralstonia solanacearum.doc by Na Chen (153323)

    Published 2025
    “…In this study, subcellular localization revealed that SlWRKY75 is located in the nucleus, while the transcriptional activation assay indicated that SlWRKY75 acts as a transcriptional activator. To investigate the functional role of SlWRKY75, we generated overexpression transgenic lines. …”
  6. 9366

    Table 1_A WRKY transcription factor, SlWRKY75, positively regulates tomato (Solanum lycopersicum L.) resistance to Ralstonia solanacearum.doc by Na Chen (153323)

    Published 2025
    “…In this study, subcellular localization revealed that SlWRKY75 is located in the nucleus, while the transcriptional activation assay indicated that SlWRKY75 acts as a transcriptional activator. To investigate the functional role of SlWRKY75, we generated overexpression transgenic lines. …”
  7. 9367

    Image 2_A WRKY transcription factor, SlWRKY75, positively regulates tomato (Solanum lycopersicum L.) resistance to Ralstonia solanacearum.tif by Na Chen (153323)

    Published 2025
    “…In this study, subcellular localization revealed that SlWRKY75 is located in the nucleus, while the transcriptional activation assay indicated that SlWRKY75 acts as a transcriptional activator. To investigate the functional role of SlWRKY75, we generated overexpression transgenic lines. …”
  8. 9368

    Data Sheet 1_Reduction of orexin-expressing neurons and a unique sleep phenotype in the Tg-SwDI mouse model of Alzheimer’s disease.pdf by Yan Wu (70890)

    Published 2025
    “…<p>Sleep disturbances are common in Alzheimer’s disease (AD) and AD-related dementia (ADRD). We performed a sleep study on Tg-SwDI mice, a cerebral amyloid angiopathy (CAA) model, and age-matched wild-type (WT) control mice. …”
  9. 9369

    Data_Sheet_1_Exercising educational equity using California’s physical fitness data: a call for more school physical fitness programs, data, and research.docx by Da’Shay Templeton (19802262)

    Published 2024
    “…The lack of safe and affordable options for physical activity coupled with the significant decrease in physical activity rates among most American children underscores the need for programs, data, and research on physical fitness in schools, where children spend a significant amount of their time. …”
  10. 9370

    The upper plots show the changes in ZMK for summer and autumn. by Peyman Karami (5909264)

    Published 2025
    “…<p>Red indicates an increasing trend and green indicates a decreasing trend in fire density. The lower plots show significant increasing and decreasing trends for different biomes in Iran.…”
  11. 9371

    Table 2_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.docx by Roberta Belli (6939221)

    Published 2025
    “…Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …”
  12. 9372

    Table 1_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.docx by Roberta Belli (6939221)

    Published 2025
    “…Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …”
  13. 9373

    Table 3_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.docx by Roberta Belli (6939221)

    Published 2025
    “…Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …”
  14. 9374

    Image 1_Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients.jpg by Roberta Belli (6939221)

    Published 2025
    “…Finally, treatment with anti-IL-23 led to a reduction in visfatin levels in female psoriatic patients and resulted in a significant decrease in fat mass percentage in men. …”
  15. 9375

    Data Sheet 1_The sigma factor σ54 (rpoN) functions as a global regulator of antibiotic resistance, motility, metabolism, and virulence in Clostridioides difficile.docx by Ying Yang (24175)

    Published 2025
    “…Additionally, rpoN deletion led to a decrease in glucose metabolic rate, which we attribute to the downregulation of glycolytic enzymes. …”
  16. 9376

    Data Sheet 1_CO2 capture from indoor air for human comfort and sequestration or reuse: a promising step toward sustainable CO2 removal.docx by Krishnendu Maity (1645408)

    Published 2025
    “…While the aqueous MEA solution experienced significantly larger declines of 54.3% in CO<sub>2</sub> absorption capacity and 34.24% in absorption kinetics, the water-PG-based Arg solution demonstrated promising performance, with a smaller reduction of 31.24% in CO<sub>2</sub> absorption and a 2.13% decrease in kinetics after ten cycles. …”
  17. 9377

    Data Sheet 2_CO2 capture from indoor air for human comfort and sequestration or reuse: a promising step toward sustainable CO2 removal.docx by Krishnendu Maity (1645408)

    Published 2025
    “…While the aqueous MEA solution experienced significantly larger declines of 54.3% in CO<sub>2</sub> absorption capacity and 34.24% in absorption kinetics, the water-PG-based Arg solution demonstrated promising performance, with a smaller reduction of 31.24% in CO<sub>2</sub> absorption and a 2.13% decrease in kinetics after ten cycles. …”
  18. 9378

    Potential of Fenfuro<sup>®</sup>, a novel, standardized <i>Trigonella foenum-graecum</i> (Fenugreek) seed extract, in ameliorating glycation-mediated amyloidogenesis by Sreemoyee Saha (20391298)

    Published 2025
    “…It was determined that these significant spectral changes were due to a combined effect of the protein as well as non-protein part of the extract and not attributable to any single bioactive component. …”
  19. 9379

    Adverse event list. by Stefan Halbherr (21353882)

    Published 2025
    “…</p><p>Methods and findings</p><p>We prospectively enrolled 12 patients with PD into a single-center, open-label phase I trial to assess the safety and tolerability of weekly infusions with TLN. …”
  20. 9380

    Patient characteristics. by Stefan Halbherr (21353882)

    Published 2025
    “…</p><p>Methods and findings</p><p>We prospectively enrolled 12 patients with PD into a single-center, open-label phase I trial to assess the safety and tolerability of weekly infusions with TLN. …”